EUCTR2005-002223-14-DK进行中（未招募）不适用
Fase II study of carboplatin and vinorelbine in malignant pleural mesothelioma - Fase II MPM
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •malignant pleural mesothelima
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •poor organ function
研究者
相似试验
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
2 期
A phase II study of carboplatin and amurubicin with a biweekly schedule in patients with advanced squamous cell lung canceron-Small Cell Lung Cancer,Squamous cell lung cancerJPRN-UMIN000007102ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine25
进行中（未招募）
2 期
A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasACTRN12616000958482Australasian Gastro-Intestinal Trials Group (AGITG)60
已完成
2 期
Phase II study of Carboplatin, Paclitaxel and Bevacizumab in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion.JPRN-UMIN000006767Shizuoka Cancer Center32
进行中（未招募）
1 期
Study to evaluate effectiveness and toxicity of combination vinorelbine, cisplatin and disulfiram and copper for treatment of breast cancer with present circulating tumor cells, who did not respond to previous therapy.MedDRA version: 20.0Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)breast cancerEUCTR2019-001957-16-SKárodný onkologický ústav